Research Analysts’ Updated EPS Estimates for January 24th (AAL, AAPL, ALXO, AMGN, ASB, AXSM, BDC, BIDU, CADE, CF)

Research Analysts’ updated eps estimates for Friday, January 24th:

American Airlines Group (NASDAQ:AAL) had its outperform rating reiterated by analysts at Raymond James. The firm currently has a $23.00 target price on the stock, down from their previous target price of $24.00.

Apple (NASDAQ:AAPL) had its buy rating reissued by analysts at Bank of America Co.. They currently have a $253.00 target price on the stock, down from their previous target price of $256.00.

ALX Oncology (NASDAQ:ALXO) had its overweight rating reiterated by analysts at Cantor Fitzgerald.

Amgen (NASDAQ:AMGN) had its outperform rating reiterated by analysts at Royal Bank of Canada. They currently have a $324.00 price target on the stock.

Associated Banc (NYSE:ASB) had its equal weight rating reissued by analysts at Stephens. They currently have a $28.00 target price on the stock.

Axsome Therapeutics (NASDAQ:AXSM) had its outperform rating reiterated by analysts at William Blair.

Belden (NYSE:BDC) had its buy rating reissued by analysts at Benchmark Co.. They currently have a $130.00 price target on the stock.

Baidu (NASDAQ:BIDU) had its buy rating reaffirmed by analysts at Benchmark Co.. They currently have a $130.00 target price on the stock.

Cadence Bank (NYSE:CADE) had its sector perform rating reissued by analysts at Royal Bank of Canada. The firm currently has a $38.00 price target on the stock.

CF Industries (NYSE:CF) had its sector underperform rating reaffirmed by analysts at Scotiabank. They currently have a $88.00 price target on the stock.

Check Point Software Technologies (NASDAQ:CHKP) had its neutral rating reaffirmed by analysts at Guggenheim.

CSX (NASDAQ:CSX) had its outperform rating reissued by analysts at Raymond James. They currently have a $37.00 price target on the stock, down from their previous price target of $38.00.

CSX (NASDAQ:CSX) had its overweight rating reiterated by analysts at Stephens. Stephens currently has a $38.00 target price on the stock.

Customers Bancorp (NYSE:CUBI) had its equal weight rating reissued by analysts at Stephens. Stephens currently has a $58.00 price target on the stock.

Covenant Logistics Group (NASDAQ:CVLG) had its overweight rating reiterated by analysts at Stephens. The firm currently has a $36.00 price target on the stock.

Dyne Therapeutics (NASDAQ:DYN) had its buy rating reiterated by analysts at Guggenheim.

Elevance Health (NYSE:ELV) had its overweight rating reissued by analysts at Cantor Fitzgerald. They currently have a $485.00 price target on the stock.

Ethan Allen Interiors (NYSE:ETD) had its market perform rating reiterated by analysts at Telsey Advisory Group. Telsey Advisory Group currently has a $32.00 price target on the stock.

First Financial Bancorp. (NASDAQ:FFBC) had its overweight rating reaffirmed by analysts at Stephens. The firm currently has a $33.00 price target on the stock.

First Mid Bancshares (NASDAQ:FMBH) had its equal weight rating reaffirmed by analysts at Stephens. The firm currently has a $43.00 target price on the stock.

Fortinet (NASDAQ:FTNT) had its neutral rating reaffirmed by analysts at Guggenheim.

Globant (NYSE:GLOB) had its buy rating reaffirmed by analysts at Needham & Company LLC. Needham & Company LLC currently has a $265.00 target price on the stock.

Grindr (NYSE:GRND) had its outperform rating reiterated by analysts at Raymond James. The firm currently has a $21.00 target price on the stock, up from their previous target price of $19.00.

MarineMax (NYSE:HZO) had its buy rating reaffirmed by analysts at Benchmark Co.. The firm currently has a $40.00 price target on the stock.

Independent Bank (NASDAQ:IBCP) had its market perform rating reissued by analysts at Keefe, Bruyette & Woods. The firm currently has a $41.00 target price on the stock, up from their previous target price of $39.00.

Imunon (NASDAQ:IMNN) had its buy rating reaffirmed by analysts at D. Boral Capital. They currently have a $29.00 target price on the stock.

First Internet Bancorp (NASDAQ:INBK) had its market perform rating reaffirmed by analysts at Keefe, Bruyette & Woods. They currently have a $40.00 target price on the stock, down from their previous target price of $45.00.

Inspire Medical Systems (NYSE:INSP) had its overweight rating reaffirmed by analysts at KeyCorp. KeyCorp currently has a $234.00 target price on the stock, down from their previous target price of $236.00.

iQIYI (NASDAQ:IQ) had its hold rating reissued by analysts at Benchmark Co..

Intuitive Surgical (NASDAQ:ISRG) had its overweight rating reissued by analysts at Piper Sandler. The firm currently has a $670.00 target price on the stock, up from their previous target price of $538.00.

Kimberly-Clark (NYSE:KMB) had its outperform rating reissued by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $165.00 target price on the stock.

Kroger (NYSE:KR) had its neutral rating reaffirmed by analysts at Citigroup Inc.. Citigroup Inc. currently has a $61.00 price target on the stock.

Levi Strauss & Co. (NYSE:LEVI) had its buy rating reaffirmed by analysts at Guggenheim. Guggenheim currently has a $23.00 target price on the stock.

Live Oak Bancshares (NASDAQ:LOB) had its market perform rating reaffirmed by analysts at Keefe, Bruyette & Woods. They currently have a $44.00 price target on the stock, down from their previous price target of $48.00.

Larimar Therapeutics (NASDAQ:LRMR) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $15.00 price target on the stock.

Microsoft (NASDAQ:MSFT) had its neutral rating reiterated by analysts at Guggenheim.

Origin Bancorp (NASDAQ:OBK) had its strong-buy rating reiterated by analysts at Raymond James. They currently have a $44.00 target price on the stock, up from their previous target price of $40.00.

OceanFirst Financial (NASDAQ:OCFC) had its equal weight rating reissued by analysts at Stephens. Stephens currently has a $22.00 price target on the stock.

Starbucks (NASDAQ:SBUX) had its outperform rating reissued by analysts at Royal Bank of Canada. They currently have a $115.00 price target on the stock.

SoFi Technologies (NASDAQ:SOFI) had its outperform rating reaffirmed by analysts at William Blair.

SouthState (NASDAQ:SSB) had its overweight rating reaffirmed by analysts at Stephens. Stephens currently has a $130.00 price target on the stock.

Third Coast Bancshares (NASDAQ:TCBX) had its outperform rating reissued by analysts at Raymond James. Raymond James currently has a $39.00 price target on the stock, up from their previous price target of $34.00.

Triumph Financial (NASDAQ:TFIN) had its underperform rating reiterated by analysts at Keefe, Bruyette & Woods. Keefe, Bruyette & Woods currently has a $80.00 price target on the stock, down from their previous price target of $85.00.

TEGNA (NYSE:TGNA) had its buy rating reissued by analysts at Guggenheim. Guggenheim currently has a $22.00 price target on the stock.

TriSalus Life Sciences (NASDAQ:TLSI) had its buy rating reiterated by analysts at Roth Mkm. Roth Mkm currently has a $11.00 target price on the stock.

Tractor Supply (NASDAQ:TSCO) had its outperform rating reissued by analysts at Telsey Advisory Group. Telsey Advisory Group currently has a $67.00 target price on the stock.

Townsquare Media (NYSE:TSQ) had its outperform rating reissued by analysts at Noble Financial. The firm currently has a $21.00 price target on the stock.

Twilio (NYSE:TWLO) had its overweight rating reaffirmed by analysts at Piper Sandler. They currently have a $142.00 target price on the stock, up from their previous target price of $94.00.

Twilio (NYSE:TWLO) had its outperform rating reaffirmed by analysts at William Blair.

Texas Instruments (NASDAQ:TXN) had its neutral rating reiterated by analysts at Cantor Fitzgerald. The firm currently has a $200.00 price target on the stock.

Texas Instruments (NASDAQ:TXN) had its buy rating reissued by analysts at Benchmark Co.. They currently have a $230.00 target price on the stock.

Union Pacific (NYSE:UNP) had its strong-buy rating reaffirmed by analysts at Raymond James. The firm currently has a $285.00 price target on the stock, up from their previous price target of $265.00.

U.S. Energy (NASDAQ:USEG) had its buy rating reaffirmed by analysts at D. Boral Capital. They currently have a $3.50 target price on the stock.

Vigil Neuroscience (NASDAQ:VIGL) had its buy rating reaffirmed by analysts at Guggenheim.

Vertex Pharmaceuticals (NASDAQ:VRTX) had its overweight rating reiterated by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $480.00 target price on the stock.

Verastem (NASDAQ:VSTM) had its buy rating reaffirmed by analysts at Guggenheim.